scholarly article | Q13442814 |
P50 | author | Katarzyna Bulek | Q92989381 |
P2093 | author name string | Jinzhong Qin | |
Xiaoxia Li | |||
Robert A Kastelein | |||
Yi Lu | |||
Booki Min | |||
Shadi Swaidani | |||
Tomasz Herjan | |||
Muhammet F Gulen | |||
Magdalena Kosz-Vnenchak | |||
Mark Aronica | |||
P2860 | cites work | TLR6: A novel member of an expanding toll-like receptor family | Q22009499 |
A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 | ||
SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms | Q24301289 | ||
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling | Q24316441 | ||
A family of human receptors structurally related to Drosophila Toll | Q24321888 | ||
T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function | Q24651566 | ||
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex | Q28239351 | ||
A toll-like receptor that prevents infection by uropathogenic bacteria | Q28504943 | ||
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
Immunologic basis of antigen-induced airway hyperresponsiveness | Q33652476 | ||
Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. | Q33920505 | ||
Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes | Q34084683 | ||
Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface | Q34152395 | ||
Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen | Q34293620 | ||
T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family | Q34377979 | ||
A role for eosinophils in airway remodelling in asthma | Q34550355 | ||
The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. | Q34614247 | ||
The role of T lymphocytes in the pathogenesis of asthma | Q35087292 | ||
To respond or not to respond: T cells in allergic asthma | Q35136010 | ||
Toward an understanding of NKT cell biology: progress and paradoxes | Q36072480 | ||
The role of T lymphocytes in asthma | Q36342179 | ||
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice | Q36362141 | ||
Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells | Q36400414 | ||
Th17: an effector CD4 T cell lineage with regulatory T cell ties | Q36510274 | ||
Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. | Q36851869 | ||
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family | Q37074042 | ||
Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. | Q39697358 | ||
Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts | Q42817686 | ||
T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses | Q42944108 | ||
Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. | Q42947124 | ||
The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function | Q42947210 | ||
Helper T cells regulate type-2 innate immunity in vivo | Q44154038 | ||
T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells. | Q52226636 | ||
IL-33 is a chemoattractant for human Th2 cells. | Q53528244 | ||
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. | Q54421098 | ||
Increased Susceptibility to Colitis-Associated Cancer of Mice Lacking TIR8, an Inhibitory Member of the Interleukin-1 Receptor Family | Q56942771 | ||
Lack of Toll IL-1R8 Exacerbates Th17 Cell Responses in Fungal Infection | Q58855382 | ||
Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking | Q73509897 | ||
T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis | Q74164997 | ||
T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation | Q80094797 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2601-2609 | |
P577 | publication date | 2009-03-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response | |
P478 | volume | 182 |
Q53070656 | A network map of IL-33 signaling pathway. |
Q46057361 | Absence of Toll-IL-1 receptor 8/single immunoglobulin IL-1 receptor-related molecule reduces house dust mite-induced allergic airway inflammation in mice |
Q38287064 | Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot? |
Q47073621 | Characterization of SIGIRR/IL-1R8 Homolog from Zebrafish Provides New Insights into Its Inhibitory Role in Hepatic Inflammation |
Q35694701 | Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis |
Q54261778 | Critical Roles of IL-33/ST2 Pathway in Neurological Disorders. |
Q38920969 | Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation |
Q36994635 | Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily |
Q92971145 | Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation |
Q89896539 | Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury |
Q44037972 | Emerging role of SIGIRR rs7396562(T/G) polymorphism in systemic lupus erythematosus in a Chinese population. |
Q37672258 | Epithelium: the interplay between innate and Th2 immunity |
Q61800535 | Exploiting NK Cell Surveillance Pathways for Cancer Therapy |
Q35134756 | Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8. |
Q41472534 | High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity. |
Q41933760 | IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor. |
Q33574472 | IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. |
Q24309034 | IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation |
Q38005217 | IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology |
Q39421781 | IL-33 and the intestine: The good, the bad, and the inflammatory |
Q36050546 | IL-33 family members and asthma - bridging innate and adaptive immune responses. |
Q39797977 | IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation |
Q47127784 | IL-33-ST2 Axis in Liver Disease: Progression and Challenge |
Q55365826 | IL-33/IL-31 Axis: A Potential Inflammatory Pathway. |
Q37990785 | IL-33/ST2 axis in inflammation and immunopathology. |
Q54255800 | IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62. |
Q41628090 | IL-37 requires IL-18Rα and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice |
Q90281729 | IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development |
Q90635035 | Immune response against Chlamydia trachomatis via toll-like receptors is negatively regulated by SIGIRR |
Q41479687 | Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa |
Q38783993 | Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer |
Q24606766 | Interleukin-1 in the pathogenesis and treatment of inflammatory diseases |
Q59351894 | Interleukin-33 and ST2 Signaling in Tumor Microenvironment |
Q38859663 | Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases |
Q37868927 | Interleukin-33 biology with potential insights into human diseases |
Q35754479 | Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation |
Q38957840 | Interleukin-33 in health and disease |
Q38770982 | Interleukin-33: increasing role in dermatological conditions |
Q61802937 | Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells |
Q34073849 | Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils |
Q21296861 | Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection |
Q35191071 | Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation |
Q36994761 | Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease |
Q47285878 | Overview of the IL-1 family in innate inflammation and acquired immunity |
Q28505577 | Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation |
Q38857818 | Preventing Overheating: Tight Control of Gut Innate Immunity in Health and Disease |
Q58764731 | Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation |
Q26752524 | Regulatory Role of IL-1R8 in Immunity and Disease |
Q37936221 | Research progress on interleukin-33 and its roles in the central nervous system |
Q55070768 | Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases. |
Q33854499 | Role of IL-33 and its receptor in T cell-mediated autoimmune diseases |
Q37922810 | Role of IL-33 in inflammation and disease |
Q35665349 | Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection |
Q38195380 | Role of interleukin 33 in respiratory allergy and asthma. |
Q35860382 | SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells |
Q38005124 | SIGIRR, a negative regulator of colon tumorigenesis |
Q41677234 | TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity |
Q39429876 | TRAIL is involved in CpG ODN-mediated anti-apoptotic signals |
Q41961424 | The GOLD domain-containing protein TMED1 is involved in interleukin-33 signaling. |
Q90084199 | The IL-1 family of cytokines and receptors in rheumatic diseases |
Q33593742 | The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases |
Q37800776 | The biological paths of IL-1 family members IL-18 and IL-33 |
Q45335760 | The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity. |
Q92782395 | The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation |
Q47285858 | The family of the interleukin-1 receptors |
Q34391415 | The interleukin-1 family: back to the future |
Q31089201 | The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus |
Q38424483 | The potential role of IL-33/ST2 signaling in fibrotic diseases |
Q36914110 | The role of IL-33 in gut mucosal inflammation. |
Q38094982 | Therapeutic potential of SIGIRR in systemic lupus erythematosus. |
Q37811063 | Transgenic modelling of cytokine polarization in the lung |
Q47285918 | Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. |
Search more.